Your browser doesn't support javascript.
loading
Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
Di Lorenzo, Flaviana; Kubik, Lukasz; Oblak, Alja; Lorè, Nicola Ivan; Cigana, Cristina; Lanzetta, Rosa; Parrilli, Michelangelo; Hamad, Mohamad A; De Soyza, Anthony; Silipo, Alba; Jerala, Roman; Bragonzi, Alessandra; Valvano, Miguel A; Martín-Santamaría, Sonsoles; Molinaro, Antonio.
  • Di Lorenzo F; From the Departments of Chemical Sciences and Department of Biotechnology, National Institute of Chemistry, Ljubljana 1000, Slovenia.
  • Kubik L; Department of Chemistry and Biochemistry, Universidad CEU San Pablo, Boadilla del Monte, Madrid 28668, Spain, Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdansk, Gdansk 80-416, Poland.
  • Oblak A; Department of Biotechnology, National Institute of Chemistry, Ljubljana 1000, Slovenia, Centre of Excellence NMR - Future Innovation for Sustainable Technologies, Ljubljana 1000, Slovenia.
  • Lorè NI; Infection and Cystic Fibrosis Unit, Istituto di Ricovero e Cura a Carattere Scientifico-San Raffaele Scientific Institute, Milan 20132, Italy.
  • Cigana C; Infection and Cystic Fibrosis Unit, Istituto di Ricovero e Cura a Carattere Scientifico-San Raffaele Scientific Institute, Milan 20132, Italy.
  • Lanzetta R; From the Departments of Chemical Sciences and.
  • Parrilli M; Biology, University of Naples Federico II, Naples 80126, Italy.
  • Hamad MA; Department of Microbiology and Immunology, University of Western Ontario, London N6A 5C1, Canada.
  • De Soyza A; Applied Immunobiology and Transplantation Group, Institute of Cellular Medicine, University of Newcastle, Newcastle NE1 7RU, United Kingdom, and.
  • Silipo A; From the Departments of Chemical Sciences and.
  • Jerala R; Department of Biotechnology, National Institute of Chemistry, Ljubljana 1000, Slovenia, Centre of Excellence NMR - Future Innovation for Sustainable Technologies, Ljubljana 1000, Slovenia.
  • Bragonzi A; Infection and Cystic Fibrosis Unit, Istituto di Ricovero e Cura a Carattere Scientifico-San Raffaele Scientific Institute, Milan 20132, Italy.
  • Valvano MA; Department of Microbiology and Immunology, University of Western Ontario, London N6A 5C1, Canada, Centre for Infection and Immunity, Queen's University Belfast, Belfast BT9 7AE, United Kingdom.
  • Martín-Santamaría S; Department of Chemistry and Biochemistry, Universidad CEU San Pablo, Boadilla del Monte, Madrid 28668, Spain, smsantamaria@cib.csic.es.
  • Molinaro A; From the Departments of Chemical Sciences and molinaro@unina.it.
J Biol Chem ; 290(35): 21305-19, 2015 Aug 28.
Article en En | MEDLINE | ID: mdl-26160169
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Burkholderia / Antígeno 96 de los Linfocitos / Receptor Toll-Like 4 / Burkholderia cenocepacia / Lípido A Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Burkholderia / Antígeno 96 de los Linfocitos / Receptor Toll-Like 4 / Burkholderia cenocepacia / Lípido A Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article